Cardiovascular Risk Factor Management in Medicare Advantage and Traditional Medicare [0.03%]
美国联邦医疗保险优势计划与传统医疗保险中的心血管危险因素管理比较研究
Andrew S Oseran,Rahul Aggarwal,Rishi K Wadhera
Andrew S Oseran
Background: Although cardiovascular disease is the leading cause of death in the United States among Medicare beneficiaries, management of modifiable risk factors remains suboptimal. Medicare Advantage (MA) enrollment has...
Response by Fauchier et al to Letter Regarding Article, "Incidence, Prevalence, and Trends in Mortality and Stroke Among Medicare Beneficiaries With Atrial Fibrillation: 2013 to 2019" [0.03%]
Fauchier等对关于文章“2013至2019年医疗保险受益人房颤的发病率、患病率和卒中死亡率变化”的来信回复
Nichole M Rogovoy,Stephen Kearing,Weiping Zhou et al.
Nichole M Rogovoy et al.
Developing a Toolkit to Reduce Infections Following Durable LVAD Implantation in the United States Using a Multistage Mixed Methods Design [0.03%]
在美国使用多阶段混合方法设计开发了一套工具包以减少长期LVAD植入后的感染
P Paul Chandanabhumma,Sriram Swaminathan,Lourdes Cabrera et al.
P Paul Chandanabhumma et al.
Background: Infections following durable left ventricular assist device (dLVAD) implantation are common and associated with increased morbidity and mortality. Despite documented interhospital variability, few studies have...
Association Between Market-Level Characteristics and Cardiologists Acquired by Private Equity in the United States [0.03%]
美国私募股权收购 cardiologist 的市场特征研究
Hamid Torabzadeh,Yashaswini Singh
Hamid Torabzadeh
Trends in Health Care Services Use and Mortality in Adults With Cardiometabolic Diseases During the First Year of the Pandemic in Ontario, Canada [0.03%]
加拿大安大略省在新冠大流行第一年患有心血管元性疾病的成年人的医疗服务利用和死亡率趋势研究
Tetyana Kendzerska,Mouaz Saymeh,Michael Pugliese et al.
Tetyana Kendzerska et al.
Background: The COVID-19 pandemic disrupted health services, particularly affecting individuals with cardiometabolic diseases. This study compared health care use and mortality trends in adults with cardiometabolic diseas...
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries [0.03%]
美国医疗保险受益人中根据梗死类型划分的心肌梗死的动态变化、患者特征及其预后情况
Amgad Mentias,Neil Keshvani,Milind Y Desai et al.
Amgad Mentias et al.
Background: Type 2 myocardial infarction (MI) is common among older adults and is associated with adverse outcomes in single-center studies. We aimed to examine temporal trends and compare outcomes between type 1 and type...
Resuming the Decline in Cardiovascular Deaths: Urgent Federal Policy Actions [0.03%]
重启心血管疾病死亡率下降的联邦政策行动刻不容缓
Anand Parekh,Rinky Bhatia
Anand Parekh
Patient and Physician Perspectives on Cardiovascular Risk: A Multicenter Survey of Communication Gaps Among Hospitalized Patients in Spain [0.03%]
西班牙住院患者中关于心血管风险的医患沟通缺口的多中心调查研究——基于医生和患者的视角
Juan Górriz-Magaña,Ramon Maruri-Sánchez,Ane Elorriaga et al.
Juan Górriz-Magaña et al.
Background: Effective risk communication is essential in managing cardiovascular disease, the leading cause of global mortality. Clear communication between patients and physicians supports informed decision-making, yet c...
Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries [0.03%]
医疗保险优势和按服务收费受益人慢性 limb-threatening 缺血内血管再血管化的结果
Katerina Dangas,Joseph M Kim,Siling Li et al.
Katerina Dangas et al.
Estimating the Stroke Risk Threshold for Initiating Non-Vitamin K Antagonist Oral Anticoagulation in Atrial Fibrillation: Markov Decision Model Analysis [0.03%]
估算启动非维生素K抗凝口服药预防房颤患者卒中的风险阈值：马尔可夫决策模型分析
Aleksi K Winstén,Ville Langén,K E Juhani Airaksinen et al.
Aleksi K Winstén et al.
Background: Randomized trials have clearly demonstrated the benefits of anticoagulant therapy in patients with atrial fibrillation who are at high risk of ischemic stroke. However, less is known about the benefit of antic...